Drug Shortage Report for JAMP-NYSTATIN ORAL SUSPENSION USP
Report ID | 189373 |
Drug Identification Number | 02433443 |
Brand name | JAMP-NYSTATIN ORAL SUSPENSION USP |
Common or Proper name | Nystatin Oral Suspension USP |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | NYSTATIN |
Strength(s) | 100000UNIT |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | A07AA |
ATC description | INTESTINALANTIINFECTIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2023-04-12 |
Estimated end date | 2024-04-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-03-11 |
Company comments | Allocations |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-04-12 | English | Compare |